Retrospective Study of Pediatric Patients With Covid-19 in Alsace in 2020-2021

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06167980

Acronym

Pedia-Cov

Enrollment

100

Registered

2023-12-13

Start date

2022-01-17

Completion date

2023-12-31

Last updated

2023-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 Pandemic

Keywords

COVID-19 Pandemic, SARS-COV-2, COVID-19 Virus Disease, Pediatric patients

Brief summary

Covid-19 is an illness that appeared in China between the end of December 2019 and the beginning of 2020 after several cases of pneumonia of undetermined etiology were reported in the Hubei province in central China. These are caused by a previously unknown coronavirus, initially named 2019-nCoV then SARS-CoV-2, which was identified on January 7, 2020 in the Bronchoalveolar Lavage (BAL) of patients hospitalized in China. As for the first European cases, they were diagnosed in France on January 24, 2020. A Chinese study published in April 2020 (4) concerning adult patients showed that 14% of these cases could be defined as severe and that 5% of cases could be defined as critical. Another Chinese study showed that all children, regardless of age, could be infected and that asymptomatic, mild and moderate cases accounted for more than 90% of cases. In France, the Covid-19 epidemic hit Alsace hard from March 2020, mainly due to the cluster formed by the evangelical assembly of the Christian Open Door Church taking place from February 17 to 21 in Mulhouse in the Haut-Rhin. Thus, it is interesting to study pediatric patients hospitalized for Covid-19 in Alsace during 2020 in order to discover the clinical characteristics of these patients.

Detailed description

The main objective of this study is to retrospectively describe the clinical, biological and radiological characteristics of pediatric patients hospitalized for Covid-19 in Alsace in 2020-2021, both in conventional service and in continuing care or intensive care.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

1 Months to 18 Years

Healthy volunteers

Inclusion criteria

* Subject aged from 1 month to 18 years * Hospitalized for Covid-19 in conventional service, continuing care or intensive care for Covid-19 or in whom SARS-CoV-2 infection was strongly suspected during the allat period from January 1, 2020 to December 31, 2021 * Subject who has not expressed, after information, his opposition to the reuse of his data for the purposes of this research * Parental authority having not expressed, after information, their opposition to the reuse of their data for the purposes of this research.

Exclusion criteria

* Subject or their parental authority having expressed their opposition to participating in the study

Design outcomes

Primary

Measure	Time frame
Retrospective description of the clinical, biological and radiological characteristics of pediatric patients hospitalized for Covid-19 in Alsace in 2020-2021	Files analysed retrospectively from period from January 1, 2020 to December 31, 2021 will be examined

Countries

France

Contacts

Primary ContactLaurence WEISS, MD

laurence.weiss@chru-strasbourg.fr33 3 88 12 83 95

Outcome results